WallStreetZenWallStreetZen

NASDAQ: SPRY
Ars Pharmaceuticals Inc Stock Ownership - Who owns Ars Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ars Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Laura ShawverDirector2025-04-0727,493$4.85
$133.34kBuy
Laura ShawverDirector2025-04-0722,509$4.85
$109.17kBuy
Laura ShawverDirector2025-04-0750,002$12.30
$615.07kSell
Eric KarasChief Commercial Officer2025-03-2010,000$14.00
$140.00kSell
Eric KarasChief Commercial Officer2025-03-2010,000$1.50
$15.00kBuy
Laura ShawverDirector2025-03-0649,600$4.85
$240.56kBuy
Laura ShawverDirector2025-03-0649,600$11.21
$556.07kSell
Laura ShawverDirector2025-03-05400$4.85
$1.94kBuy
Laura ShawverDirector2025-03-05400$11.00
$4.40kSell
Laura ShawverDirector2025-02-039,064$3.15
$28.55kBuy

1 of 18

SPRY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SPRY insiders and whales buy or sell their stock.

SPRY Shareholders

What type of owners hold Ars Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC17.36%17,029,398$240.80MInsider
Peter A. Thompson17.36%17,029,398$240.80MInsider
Richard E. Lowenthal14.57%14,291,828$202.09MInsider
Sarina Tanimoto12.89%12,649,635$178.87MInsider
Ra Capital Management LP11.07%10,860,977$153.57MInstitution
James E. Flynn10.72%10,514,657$148.68MInsider
Deerfield Management Company LP Series C10.72%10,514,657$148.68MInstitution
Orbimed Advisors LLC8.45%8,288,510$117.20MInstitution
Pratik Shah4.92%4,824,554$68.22MInsider
Blackrock Inc4.66%4,574,491$64.68MInstitution

1 of 3

SPRY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SPRY44.08%55.92%Net SellingNet Buying
MESO0.26%0.00%
CLDX85.28%14.72%Net Buying
DYN78.17%21.83%Net SellingNet Selling
OCUL78.69%21.31%Net SellingNet Selling
View Top Biotech Stocks

Ars Pharmaceuticals Stock Ownership FAQ

Who owns Ars Pharmaceuticals?

Ars Pharmaceuticals (NASDAQ: SPRY) is owned by 72.64% institutional shareholders, 92.16% Ars Pharmaceuticals insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Ars Pharmaceuticals shareholder, owning 17.03M shares representing 17.36% of the company. Orbimed Advisors LLC's Ars Pharmaceuticals shares are currently valued at $237.05M.

If you're new to stock investing, here's how to buy Ars Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.